Cargando…

HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases

High-mobility group box 1 (HMGB1) is a nuclear protein that can also act as an extracellular trigger of inflammation, proliferation, and migration in eye diseases. It induces signaling pathways by binding to the receptor for advanced glycation end products (RAGE) and Toll-like receptors (TLRs) 2, 4,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yi, Zhuang, Guo-Bin, Zhou, Xue-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220384/ https://www.ncbi.nlm.nih.gov/pubmed/30473885 http://dx.doi.org/10.1155/2018/5195290

Ejemplares similares

HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression
por: Huang, Xiao, et al.
Publicado: (2023)

Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Pathogenesis of Common Ocular Diseases
por: Zhang, Jun, et al.
Publicado: (2015)

The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
por: Hanaford, Allison, et al.
Publicado: (2022)

The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies
por: Zhao, Lijuan, et al.
Publicado: (2021)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
por: Wen, Zhonghui, et al.
Publicado: (2004)

Heme Cytotoxicity and the Pathogenesis of Immune-Mediated Inflammatory Diseases
por: Larsen, Rasmus, et al.
Publicado: (2012)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
por: Chakravorty, Anushka, et al.
Publicado: (2019)

Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice
por: Tan, Juan, et al.
Publicado: (2012)

Trained Immunity: An Underlying Driver of Inflammatory Atherosclerosis
por: Zhong, Chao, et al.
Publicado: (2020)

Pathogenesis and Manifestations of Zika Virus-Associated Ocular Diseases
por: Labib, Bisant A., et al.
Publicado: (2022)

Advances in pathogenesis and treatment of ocular involvement in Behcet’s disease
por: Lin, Suibin, et al.
Publicado: (2023)

Arginine metabolism regulates the pathogenesis of inflammatory bowel disease
por: Li, Jun-Yi, et al.
Publicado: (2022)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

The Role of Innate Immunity Receptors in the Pathogenesis of Inflammatory Bowel Disease
por: Elia, Paula Peruzzi, et al.
Publicado: (2015)

The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis
por: Drummond, Eleanor, et al.
Publicado: (2017)

Editorial: Fibrotic tissue remodeling as a driver of disease pathogenesis
por: Basak, Trayambak, et al.
Publicado: (2023)

Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases
por: Chen, Meini, et al.
Publicado: (2022)

Research progress of exosomes in pathogenesis, diagnosis, and treatment of ocular diseases
por: Feng, Xinting, et al.
Publicado: (2023)

Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators
por: Wang, Li, et al.
Publicado: (2020)

HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation
por: Han, S J, et al.
Publicado: (2015)

Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
por: Grundtman, Cecilia, et al.
Publicado: (2007)

Dry Eye: an Inflammatory Ocular Disease
por: Hessen, Michelle, et al.
Publicado: (2014)

Ocular Complications of Inflammatory Bowel Disease
por: Mady, Rana, et al.
Publicado: (2015)

Ocular Manifestations of Inflammatory Bowel Disease
por: Licona Vera, Erik, et al.
Publicado: (2023)

Microbiota and Ocular Diseases
por: Xue, Wei, et al.
Publicado: (2021)

Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
por: Baci, Denisa, et al.
Publicado: (2020)

Immune modulating nanoparticles for the treatment of ocular diseases
por: Fang, Lianfei, et al.
Publicado: (2022)

Ocular immune privilege
por: Zhou, Ru, et al.
Publicado: (2010)

Incidence of ocular and systemic diseases affecting visual function among state bus drivers
por: Kohli, Piyush, et al.
Publicado: (2021)

Microbiota as Drivers and as Therapeutic Targets in Ocular and Tissue Specific Autoimmunity
por: Salvador, Ryan, et al.
Publicado: (2021)

Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
por: Mallone, Fabiana, et al.
Publicado: (2021)

Bacterial Translocation as Inflammatory Driver in Crohn’s Disease
por: Linares, Raquel, et al.
Publicado: (2021)

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
por: Wang, Yucheng, et al.
Publicado: (2020)

Editorial for Special Issue “Advances in the Pathogenesis and Treatment of Immune-Mediated Inflammatory Diseases”
por: van Hamburg, Jan Piet, et al.
Publicado: (2022)

Multiomic landscape of immune pathogenesis in Kimura’s disease
por: Wu, Xunyao, et al.
Publicado: (2023)

Inflammatory Immune Responses in the Pathogenesis of Tick-Borne Encephalitis
por: Bogovič, Petra, et al.
Publicado: (2019)

APOBEC: A molecular driver in cervical cancer pathogenesis
por: Revathidevi, Sundaramoorthy, et al.
Publicado: (2021)

“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer
por: Avril, Marion, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_drh7bkim00i4fhs911n1iv1gnt